BVS
BVS
NASDAQ · Health Care

Bioventus Inc - A

$13.89
-0.03 (-0.18%)
As of Aug 15, 1:52 AM ET ·
Financial Highlights (FY 2026)
Revenue
693.19M
Net Income
27.74M
Gross Margin
68.3%
Profit Margin
4.0%
Rev Growth
+3.5%
D/E Ratio
1.65
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 693.19M 669.62M 241.82M 197.18M
Gross Profit 473.66M 457.55M 110.34M 89.97M
Operating Income 65.44M 56.89M 36.38M 29.11M
Net Income 27.74M 24.12M 36.10M 22.67M
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Rev Growth +3.5% +3.5% -4.8% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 363.55M 363.55M 254.88M 304.50M
Total Equity 220.47M 220.47M 321.56M 308.93M
D/E Ratio 1.65 1.65 0.79 0.99
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 72.45M 66.49M 52.99M 46.00M
Free Cash Flow 25.01M 12.86M